ClinicalTrials.govpublic full text
Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience
hiv infection, metabolic syndrome, antiretroviral treatment, hiv, dual-therapy, bic/taf/ftc, dtg/3tc, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 903513
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.